Table 1:
Baseline data in SAP group and MAP group [n(%)]/(x¯±SD)
| Classification | SAP group (n=104) | MAP group (n=101) | Z/t/χ2 | P |
|---|---|---|---|---|
| Sex | 0.210 | 0.647 | ||
| Male | 63 (60.58) | 58 (57.43) | ||
| Female | 41 (39.42) | 43 (42.57) | ||
| Age (years) | 59.7±8.9 | 59.7±8.9 | 1.170 | 0.243 |
| BMI (kg/m2) | 22.84±2.14 | 22.76±2.19 | 0.264 | 0.792 |
| Smoking history | 0.371 | 0.542 | ||
| Yes | 44 (42.31) | 47 (46.53) | ||
| No | 60 (57.69) | 54 (53.47) | ||
| Drinking history | 0.358 | 0.550 | ||
| Yes | 46 (44.23) | 50 (49.50) | ||
| No | 58 (55.77) | 51 (50.50) | ||
| Diabetes mellitus | 3.185 | 0.074 | ||
| Yes | 22 (21.15) | 12 (11.88) | ||
| No | 82 (78.85) | 89 (88.12) | ||
| APACHE-II score | 10.8±3.2 | 6.9±3.1 | 8.859 | <0.001 |
| Ranson score | 2.0±0.7 | 1.6±0.9 | 3.558 | <0.001 |
| Pathogenic factors | 3.524 | 0.620 | ||
| Cholecystolithiasis | 40 (38.46) | 35 (34.65) | ||
| Choledocholithiasis | 11 (10.58) | 10 (9.90) | ||
| Overeating | 4 (3.85) | 2 (1.99) | ||
| Cholecystitis | 14 (13.46) | 23 (22.77) | ||
| Alcoholic | 26 (25.00) | 24 (23.76) | ||
| Hyperlipemia | 9 (8.65) | 7 (6.93) | ||
| Blood amylase (U/L) | 977.89 (510.36–1663.16) | 967.20 (535.56–1433.15) | −0.403 | 0.687 |
| Urine amylase (U/L) | 2798.40 (1426.59–4024.48) | 2404.20 (1067.02–4010.66) | −1.286 | 0.199 |
| Platelet (×109/L) | 150.18 (108.06–194.77) | 152.80 (112.49–184.81) | −0.291 | 0.771 |
| Leukocyte (×109/L) | 15.83±5.94 | 15.23±4.74 | 0.798 | 0.426 |
| TC (mmol/L) | 3.21±1.02 | 3.34±1.35 | 0.779 | 0.437 |
| HDL (mg/L) | 0.91±0.38 | 0.89±0.22 | 0.459 | 0.646 |
| BUN (mmol/L) | 13.64 (6.70–19.38) | 12.04 (7.53–15.72) | −1.308 | 0.191 |
| ALT (U/L) | 55.01 (30.92–83.99) | 55.71 (39.16–74.48) | −0.148 | 0.882 |
| AST (U/L) | 80.48 (50.46–122.34) | 78.48 (49.57–110.28) | −0.820 | 0.412 |
| TB (μmol/L) | 45.44 (79.80–62.20) | 41.07 (28.86–53.26) | −1.717 | 0.086 |